Science Resources
Earth Science
Space Science
Life Science
Fields of Scientific Study
Medical Topics and Fields
Cancer Research
Nanotechnology Articles
RSS Feeds
|
 |
 |
 |
New screening strategy for detection of chagas disease in children
December 26, 2007
A new targeted screening strategy could make the diagnosis and treatment of Chagas disease more feasible in low-resource settings, concludes a new study, publishing on December 26, 2007, in the open-access journal PLoS Neglected Tropical Diseases. Trypanosoma cruzi, the single-cell parasite that causes Chagas disease, is transmitted by triatomine bugs that infest houses in poor communities. The disease, which infects an estimated 11 million people in Latin America, kills more people than any other parasitic disease in the Americas.
Chagas disease control programs have traditionally focused on interrupting the transmission of T. cruzi through vector control measures (such as insecticide spraying), rather than on active case detection and specific treatment of infected people. While control actions have reduced the geographic range and prevalence of major triatomine vectors, without attention to timely diagnosis of those already infected, the window of opportunity for effective treatment (such as giving anti-parasitic drugs) is missed. An important reason for the low rates of treatment is that health services and control programs in Latin America lack sufficient resources for comprehensive blood screening and supervised treatment in the most affected areas.
The study, by Michael Levy (Emory University and the Centers for Disease Control and Prevention, Atlanta, USA, currently at the Fogarty International Center of the NIH) and colleagues, demonstrates an alternative screening strategy that could potentially be much more efficient and cost-effective, and therefore much more viable in the resource-poor regions plagued by the disease.
The researchers performed a serological survey in children 2-18 years old living in a peri-urban community of Arequipa, Peru, where a vector control campaign is currently disrupting transmission of T. cruzi. They found that 5.3% of children had already been infected by the time their households received insecticide application. They also found that households with infected children were significantly clustered spatially around each other.
The researchers then related their findings to data that had been collected during the vector control campaign (entomological, spatial, and census data). They found that using such data to target diagnostic testing would have identified over 83% of the infected children while testing only 22% of eligible children (only 22% would have to be tested because of the way the households with infected children clustered).
Levy and colleagues conclude that data easily collected during an ongoing insecticide spraying campaign in Arequipa could be used to identify children at greatest risk of infection with T. cruzi.
The study is the first, according to the authors, to describe T. cruzi transmission in an urban environment and to show evidence that transmission may be epidemic in Arequipa.
In a related commentary article also publishing on December 26, 2007, in PLoS Neglected Tropical Diseases, Ricardo Gürtler (University of Buenos Aires, Argentina), an internationally recognized authority on Chagas disease, commended Levy and colleagues' study, saying "the usual approaches to active case detection require surveying the whole population at risk, and therefore are labor-intensive and costly. It is in this context that the article by Levy et al. attains high relevance for the pending task of massive case detection and treatment of infected children in resource-poor settings."
Public Library of Science
|
 |
Related Chagas Disease Current Events and Chagas Disease News Articles Chagas Disease Current Events and Chagas Disease News RSS How much is the world spending on neglected disease research and development? The first comprehensive survey of global spending on neglected disease R&D, published in this week's PLoS Medicine, finds that just over $US 2.5 billion was invested into R&D of new products in 2007, with three diseases-HIV/AIDS, TB, and malaria-receiving nearly 80% of the total.
Scans show immune cells intercepting parasites Researchers may have identified one of the body's earliest responses to a group of parasites that causes illness in developing nations.
UCSF marks a milestone with 500th transplant in heart and lung program UCSF marked a milestone this week with the 500th procedure in its Thoracic Transplant Program, which specializes in transplantation of the heart and lung.
Survival rates exceed national averages for UCSF heart, liver and lung transplant programs One-year survival rates for patients receiving heart, liver and lung transplants at UCSF Medical Center exceed national averages at statistically significant levels, according to new data compiled by the Scientific Registry of Transplant Recipients (SRTR).
New drug combination shows promise for African sleeping sickness A small clinical trial in Uganda, conducted within a long-established Médecins Sans Frontières (MSF) treatment program for African sleeping sickness, has found that a new combination treatment using the drugs nifurtimox and eflornithine holds promise and deserves further evaluation.
Study finds multiple neglected tropical diseases effectively treated with drugs The neglected tropical diseases are a group of 13 infectious diseases, including elephantiasis, hookworm, African sleeping sickness and trachoma, which affect more than 1 billion people worldwide, most of whom live in extreme poverty.
Data on Life Expectancy Show Many Countries Clustered in High Mortality Traps Growing recognition of the importance of health as a contributing factor to economic development and societal change has prompted the Proceedings of the National Academy of Sciences (PNAS) to add a new subsection in Sustainable Health to its existing section on Sustainable Development.
Leeches ferry infection among newts Parasite-carrying bloodsucking leeches may be delivering a one-two punch to newts, according to biologists, who say the discovery may provide clues to disease outbreaks in amphibians.
Bioprospecting not biopiracy By training professionals in high-biodiversity regions to advance the drug discovery process in-country, a novel program drives drug discovery costs down as it promotes tropical biodiversity conservation.
A case of mistaken molecular identity Researchers in Argentina have determined that night blindness is a new clinical symptom of Chagas disease. More Chagas Disease Current Events and Chagas Disease News Articles
|
 |
|
|
Chagas Disease in the Americas: The Kiss of Death
by Joseph William Bastien (Author)
|

|
Chagas Disease Toolkit - Comprehensive Medical Encyclopedia with Treatment Options, Clinical Data, and Practical Information (Two CD-ROM Set)
by U.S. Government (Author)
This up-to-date and comprehensive set of two CD-ROM discs provides a superb collection of official Federal government documents on the subject of chagas disease. Chagas disease is caused by a parasite. It is common in Latin America but not in the United States. Infected blood-sucking bugs, sometimes called kissing bugs, spread it. When an infected bug bites you, usually on your face, it leaves behind infected waste. You can get the infection if you rub it in your eyes or nose, the bite wound or a cut. The disease can also spread through contaminated food, a blood transfusion, a donated organ or from mother to baby during pregnancy. For patients, practical information is provided in clearly written patient education documents. For medical professionals, doctor reference tools and texts...
|

|
Molecular Mechanisms of Pathogenesis in Chagas' Disease (Medical Intelligence Unit)
by John M. Kelly (Editor)
Chagas' disease, which results from infection with the single cell parasite Trypanosoma cruzi, is a debilitating condition that is a major problem in many parts of Latin America. Rapid technical progress is now facilitating dissection of the molecular mechanisms of disease pathogenesis, a process that will ultimately provide new strategies to alleviate the enormous public health burden associated with the infection. In this book, international experts review the buoyant status of Chagas' disease research as we enter the "post-genome" era and speculate on how the new findings will impact on drug and vaccine development. The chapters outline how progress is being made on several fronts ranging from parasite population genetics to human immunology. Researchers, physicians and students with...
|
|
|
Trypanosomiasis and Leishmaniasis with Special Reference to Chagas' Disease (Ciba Foundation Symposium)
by Katherine, Maeve O'Connor, G. E. W. Wolstenholme, editors Elliott (Author)
|
|
|
Screening blood supply for Trypanosoma cruzi nears: Chagas' disease pathogen.(Clinical Rounds): An article from: Family Practice News
by Mitchel L. Zoler (Author)
This digital document is an article from Family Practice News, published by International Medical News Group on February 1, 2004. The length of the article is 632 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details Title: Screening blood supply for Trypanosoma cruzi nears: Chagas' disease pathogen.(Clinical Rounds) Author: Mitchel L. Zoler Publication: Family Practice News (Magazine/Journal) Date: February 1, 2004 Publisher: International Medical News Group Volume: 34 Issue: 3 Page: 50(1)
Distributed by Thomson...
|
|
|
Chagas' Disease Vectors, Vol 3: Biochemical Aspects & Control
by Rodolfo R. Brenner (Author), Angel De LA Merced Stoka (Editor)
|

|
2009 Conquering Chagas Disease - The Empowered Patient's Complete Reference - Diagnosis, Treatment Options, Prognosis (Two CD-ROM Set)
by PM Medical Health News (Author)
This up-to-date and comprehensive set of two CD-ROM discs provides a superb collection of official Federal government documents on the subject of chagas disease. Chagas disease is caused by a parasite. It is common in Latin America but not in the United States. Infected blood-sucking bugs, sometimes called kissing bugs, spread it. When an infected bug bites you, usually on your face, it leaves behind infected waste. You can get the infection if you rub it in your eyes or nose, the bite wound or a cut. The disease can also spread through contaminated food, a blood transfusion, a donated organ or from mother to baby during pregnancy. For patients, practical information is provided in clearly written patient education documents. For medical professionals, doctor reference tools and texts...
|
|
|
T. cruzi rising, universal blood screening urged; Chagas' disease pathogen.(Clinical Rounds): An article from: Skin & Allergy News
by Mitchel L. Zoler (Author)
This digital document is an article from Skin & Allergy News, published by International Medical News Group on March 1, 2004. The length of the article is 626 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details Title: T. cruzi rising, universal blood screening urged; Chagas' disease pathogen.(Clinical Rounds) Author: Mitchel L. Zoler Publication: Skin & Allergy News (Magazine/Journal) Date: March 1, 2004 Publisher: International Medical News Group Volume: 35 Issue: 3 Page: 30(1)
Distributed by Thomson...
|

|
Chagas Disease
by Frederic P. Miller (Editor), Agnes F. Vandome (Editor), John McBrewster (Editor)
Chagas disease (Portuguese: doença de Chagas, Spanish: enfermedad de Chagas-Mazza, mal de Chagas in both languages; also called American trypanosomiasis) is a tropical parasitic disease caused by the flagellate protozoan Trypanosoma cruzi. T. cruzi is commonly transmitted to humans and other mammals by an insect vector, the blood-sucking assassin bugs of the subfamily Triatominae (family Reduviidae) most commonly species belonging to the Triatoma, Rhodnius, and Panstrongylus genera. The disease may also be spread through blood transfusion and organ transplantation, ingestion of food contaminated with parasites, and from a mother to her fetus. The symptoms of Chagas disease vary over the course of an infection. In the early, acute stage, symptoms are mild and usually produce no more than...
|
|
|
Oral transmission of Chagas disease by consumption of acai palm fruit, Brazil.(THE AMAZON REGION: DISPATCHES): An article from: Emerging Infectious Diseases
by Aglaer A. Nobrega (Author), Marcio H. Garcia (Author), Erica Tatto (Author), Marcos T. Obara (Author), Elenild Costa (Author), Jeremy Sobel (Author), Wildo N. Araujo (Author)
This digital document is an article from Emerging Infectious Diseases, published by U.S. National Center for Infectious Diseases on April 1, 2009. The length of the article is 2184 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.
Citation Details Title: Oral transmission of Chagas disease by consumption of acai palm fruit, Brazil.(THE AMAZON REGION: DISPATCHES) Author: Aglaer A. Nobrega Publication: Emerging Infectious Diseases (Magazine/Journal) Date: April 1, 2009 Publisher: U.S. National Center for Infectious Diseases Volume: 15 Issue: 4 Page: 653(3)
Distributed by Gale, a part of Cengage...
|
|